Reason for request
Assessment of the dosage change permitting use in children.
Clinical Benefit
| Substantial |
The actual benefit of this medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
The medicinal product SMOFLIPID has the same actual benefit in the paediatric population as previously recognised by the transparency Committee in adults (IAB V). |
eNq1mF1v2jAUhu/5FVEudkcCBQpsCdXG2g2p1RgFbdoNMslJMQt26g+g/fVzCKh0csZq8GXi5D3HPsePXzm42ixTZwWMY0pCt+7VXAdIRGNMHkJ3Mr6pdtyrXiVYoBU6+Kzt1bz6hetEKeI8dPNRbwaIcO/n3e1nUP8Dc3sVJ6CzBUTi1XdS4NT7ivj8DmX5N06wojh2liDmNA7dTIrtWyfggqksemvKfvMMRRD4uzeHo4tp8/B94Odi/6EqObBbRB60okCMNCPJGBDRRwIeKHsqybdhpI35CDiVLIIhEvMhoyscQ6wNkaCUg1GQZB3fA1ulIPIgWnF/ES25kThaoM0IHgf6pD+q0b7YiGqtWm+3u63WZbPTbnS7RqHYwVLpq6Am4UfTbrPZurzwgfh8SZMUZzg2LM6QMoFSS2XBvP+6syzFYfB4tPwx5lmKnrwFz0yXCjGkhoGp/W9vIvkMxkwRKVVr9pc+kWnqvzHryY4XljLOcdSnkogSbNyMTBeiT4mATXlFzUgnNrtexMDPJ/tMiZ7yQzlLcWTKNEUdCVxMRoNypJ2VBp8Qhwmzh4MfmMR0zc+PmcOyWso+25JSK5qxuD696HYu662W8S76pXqo5Iy5loxm4CsAYX4KVwYkoacSRbWlXmrflOfrx63VoRFKocTsVA3pohpx782stbq9bVQMaEW/XI9N++O7BPZ0v33USuM43FfWjLw2cK6a8VjexbYNs2mj1up0G813aJl92Jvo0NAwF6JW/LJkesbMhcj4e99fr9feHPEqR2o9vYT94xC40s79HPNXxH0ppz1Pb8UCFJaooK2l1GfFMfq2Oppu3GMm4VTju/t/Z7C1MQSTcEItCsZbI/Hg+vxwf3G91tIevmKMvTBbh4oEpsSWcZIzreJJx4kqK7lhig/fkgSXXLGUtmXgF9c7vUrg51c7vcofcYgCxg==
GBpVRwrsjrk1SPq1
